2'-Deoxy-2'-fluoroguanosine is a nucleoside analog where the 2'-hydroxyl group of the ribose sugar is replaced by a fluorine atom. This structural modification enhances its metabolic stability against cellular nucleoside-degrading enzymes and alters its interaction with viral polymerases. This compound serves as a key intermediate in the synthesis of several important antiviral prodrugs. Most notably, it is a critical precursor for sofosbuvir (PSI-7977), a direct-acting antiviral agent and a cornerstone in the treatment of chronic hepatitis C virus (HCV) infection. The 2'-fluoro modification is crucial for the drug's mechanism of action, acting as a chain terminator during viral RNA replication by the HCV NS5B polymerase. As a specialized nucleoside building block, its primary and almost exclusive commercial and research significance lies in pharmaceutical development, specifically for antiviral therapeutics. Its handling requires standard precautions for laboratory chemicals.